Mark C. de Gooijer
- Molecular Biology top 10%
- Genetics top 2%
- Oncology top 5%
- Biomedical Engineering top 10%
- Biomaterials top 5%
- Co-authors
- Olaf van TellingenTom WürdingerPieter WesselingHelga E. de VriesBahar Yetkin-ArikJos H. BeijnenLevi C.M. BuilThomas Würdinger
- Topics
- Drug Transport and Resistance Mechanisms (14 papers)Glioma Diagnosis and Treatment (13 papers)Cancer Mechanisms and Therapy (4 papers)
- Cited by
- GeneticsBiomaterialsOncology
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Mark C. de Gooijer
33 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Molecular Biology 781
- Genetics 579
- Oncology 474
- Biomedical Engineering 378
- Biomaterials 311
Countries citing papers authored by Mark C. de Gooijer
This map shows the geographic impact of Mark C. de Gooijer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. de Gooijer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. de Gooijer more than expected).
Fields of papers citing papers by Mark C. de Gooijer
This network shows the impact of papers produced by Mark C. de Gooijer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. de Gooijer. The network helps show where Mark C. de Gooijer may publish in the future.
Co-authorship network of co-authors of Mark C. de Gooijer
This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. de Gooijer. A scholar is included among the top collaborators of Mark C. de Gooijer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. de Gooijer. Mark C. de Gooijer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 3 | |
| 5 | 5 | |
| 6 | 1 | |
| 7 | 16 | |
| 8 | 1 | |
| 9 | 8 | |
| 10 | 4 | |
| 11 | 43 | |
| 12 | 32 | |
| 13 | 49 | |
| 14 | 48 | |
| 15 | 8 | |
| 16 | 64 | |
| 17 | 69 | |
| 18 | Overcoming the blood–brain tumor barrier for effective glioblastoma treatmentbreakdown → | 764 |
| 19 | 105 | |
| 20 | 6 |
About Mark C. de Gooijer
Mark C. de Gooijer is a scholar working on Genetics, Structural Biology and Oncology, having authored 35 papers that have together received 1.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (14 papers), Glioma Diagnosis and Treatment (13 papers) and Cancer Mechanisms and Therapy (4 papers). The work is most often cited by research in Genetics (579 citations), Biomaterials (311 citations) and Oncology (474 citations). Mark C. de Gooijer has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Olaf van Tellingen, Tom Würdinger, Pieter Wesseling, Helga E. de Vries, Bahar Yetkin-Arik, Jos H. Beijnen, Levi C.M. Buil, Thomas Würdinger, René Bernards and Ping Zhang. Their work appears in journals such as Analytical Chemistry, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.